Wednesday, February 23, 2022

US FDA News: Arrow International, LLC (Subsidiary of Teleflex Inc.) Recalls the Arrow-Trerotola Percutaneous Thrombolytic Device Due to Risk of Tip Damage During Use

Arrow International, LLC is recalling its Arrow-Trerotola Percutaneous Thrombolytic Device due to potential tip damage during use.


Read more: Arrow International, LLC (Subsidiary of Teleflex Inc.) Recalls the Arrow-Trerotola Percutaneous Thrombolytic Device Due to Risk of Tip Damage During Use